Current Infectious Disease Reports

, Volume 7, Issue 3, pp 204–210

Human metapneumovirus: An important cause of respiratory disease in children and adults

  • John V. Williams


Human metapneumovirus is a paramyxovirus that was discovered in 2001 in the Netherlands. Epidemiologic studies have shown it to be a major cause of acute respiratory tract disease in normal infants and children worldwide, with a seasonal occurrence and spectrum of clinical illness most similar to the closely related respiratory syncytial virus. The greatest prevalence of severe disease requiring hospitalization in otherwise healthy children appears to be in those aged between 6 and 12 months, older than the peak age of hospitalizations for respiratory syncytial virus. Human metapneumovirus is also a significant cause of acute respiratory disease in adults, particularly the elderly and those with comorbid conditions such as chronic obstructive pulmonary disease, asthma, and cancer. Because there is no rapid diagnostic assay, reverse transcriptase polymerase chain reaction is most widely used. Animal models have been developed, and candidate live-attenuated vaccines are in preclinical trials, offering the potential for future interventions in high-risk groups.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    World Health Organization: Acute respiratory infection in children. resp_infections/en/. Accessed January 10, 2005.Google Scholar
  2. 2.
    Glezen WP, Loda FA, Clyde WA Jr, et al.: Epidemiologic patterns of acute lower respiratory disease of children in a pediatric group practice. J Pediatr 1971, 78:397–406.PubMedCrossRefGoogle Scholar
  3. 3.
    Henderson FW, Clyde WA Jr, Collier AM, et al.: The etiologic and epidemiologic spectrum of bronchiolitis in pediatric practice. J Pediatr 1979, 95:183–190.PubMedCrossRefGoogle Scholar
  4. 4.
    van den Hoogen BG, DeJong JC, Groen J, et al.: A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 2001, 7:719–724. This is the initial report of the discovery and characterization of hMPV. It contains extensive data regarding biochemical characterization, genomic sequencing, electron microscopy, and animal studies of hMPV.PubMedCrossRefGoogle Scholar
  5. 5.
    Williams JV, Harris PA, Tollefson SJ, et al.: Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N Engl J Med 2004, 350:443–450. This is a large prospective study of outpatient children, conducted over a 25-year period, that provides robust comparison data between hMPV and other common respiratory viruses in a single cohort.PubMedCrossRefGoogle Scholar
  6. 6.
    MacPhail M, Schickli JH, Tang RS, et al.: Identification of small-animal and primate models for evaluation of vaccine candidates for human metapneumovirus (hMPV) and implications for hMPV vaccine design. J Gen Virol 2004, 85:1655–1663.PubMedCrossRefGoogle Scholar
  7. 7.
    Skiadopoulos MH, Biacchesi S, Buchholz UJ, et al.: The two major human metapneumovirus genetic lineages are highly related antigenically, and the fusion (F) protein is a major contributor to this antigenic relatedness. J Virol 2004, 78:6927–6937.PubMedCrossRefGoogle Scholar
  8. 8.
    Boivin G, Abed Y, Pelletier G, et al.: Virological features and clinical manifestations associated with human metapneumovirus: a new paramyxovirus responsible for acute respiratory tract infections in all age groups. J Infect Dis 2002, 186:1330–1334.PubMedCrossRefGoogle Scholar
  9. 9.
    Bastien N, Ward D, Van Caeseele P, et al.: Human metapneumovirus infection in the Canadian population. J Clin Microbiol 2003, 41:4642–4646.PubMedCrossRefGoogle Scholar
  10. 10.
    van den Hoogen BG, van Doornum GJ, Fockens JC, et al.: Prevalence and clinical symptoms of human metapneumovirus infection in hospitalized patients. J Infect Dis 2003, 188:1571–1577.PubMedCrossRefGoogle Scholar
  11. 11.
    Peiris JS, Tang WH, Chan KH, et al.: Children with respiratory disease associated with metapneumovirus in Hong Kong. Emerg Infect Dis 2003, 9:628–633. This is a prospective study of hospitalized children with hMPV infection that provides comparisons with RSV and influenza in the same population.PubMedGoogle Scholar
  12. 12.
    Boivin G, De Serres G, Cote S, et al.: Human metapneumovirus infections in hospitalized children. Emerg Infect Dis 2003, 9:634–640.PubMedGoogle Scholar
  13. 13.
    Freymouth F, Vabret A, Legrand L, et al.: Presence of the new human metapneumovirus in French children with bronchiolitis. Pediatr Infect Dis J 2003, 22:92–94.PubMedCrossRefGoogle Scholar
  14. 14.
    Maggi F, Pifferi M, Vatteroni M, et al.: Human metapneumovirus associated with respiratory tract infections in a 3-year study of nasal swabs from infants in Italy. J Clin Microbiol 2003, 41:2987–2991.PubMedCrossRefGoogle Scholar
  15. 15.
    Viazov S, Ratjen F, Scheidhauer R, et al.: High prevalence of human metapneumovirus infection in young children and genetic heterogeneity of the viral isolates. J Clin Microbiol 2003, 41:3043–3045.PubMedCrossRefGoogle Scholar
  16. 16.
    Thanasugarn W, Samransamruajkit R, Vanapongtipagorn P, et al.: Human metapneumovirus infection in Thai children. Scand J Infect Dis 2003, 35:754–756.PubMedCrossRefGoogle Scholar
  17. 17.
    IJpma FF, Beekhuis D, Cotton MF, et al.: Human metapneumovirus infection in hospital referred South African children. J Med Virol 2004, 73:486–493.PubMedCrossRefGoogle Scholar
  18. 18.
    Galiano M, Videla C, Puch SS, et al.: Evidence of human metapneumovirus in children in Argentina. J Med Virol 2004, 72:299–303.PubMedCrossRefGoogle Scholar
  19. 19.
    Ebihara T, Endo R, Kikuta H, et al.: Human metapneumovirus infection in Japanese children. J Clin Microbiol 2004, 42:126–132.PubMedCrossRefGoogle Scholar
  20. 20.
    Cuevas LE, Nasser AM, Dove W, et al.: Human metapneumovirus and respiratory syncytial virus, Brazil. Emerg Infect Dis 2003, 9:1626–1628.PubMedGoogle Scholar
  21. 21.
    Zhu RN, Qian Y, Deng J, et al.: Human metapneumovirus may associate with acute respiratory infections in hospitalized pediatric patients in Beijing, China. Zhonghua Er Ke Za Zhi 2003, 41:441–444.PubMedGoogle Scholar
  22. 22.
    Esper F, Martinello RA, Boucher D, et al.: A 1-year experience with human metapneumovirus in children aged < 5 years. J Infect Dis 2004, 189:1388–1396.PubMedCrossRefGoogle Scholar
  23. 23.
    Dollner H, Risnes K, Radtke A, Nordbo SA: An outbreak of human metapneumovirus infection in Norwegian children. Pediatr Infect Dis J 2004, 23:436–440.PubMedCrossRefGoogle Scholar
  24. 24.
    McAdam AJ, Hasenbein ME, Feldman HA, et al.: Human metapneumovirus in children tested at a tertiary-care hospital. J Infect Dis 2004, 190:20–26.PubMedCrossRefGoogle Scholar
  25. 25.
    Mullins JA, Erdman DD, Weinberg GA, et al.: Human metapneumovirus infection among children hospitalized with acute respiratory illness. Emerg Infect Dis 2004, 10:700–705. This is a population-based study of all children hospitalized in two urban areas that thus provides population-based estimates of prevalence.PubMedGoogle Scholar
  26. 26.
    Bosis S, Esposito S, Niesters HG, et al.: Impact of human metapneumovirus in childhood: comparison with respiratory syncytial virus and influenza viruses. J Med Virol 2005, 75:101–104.PubMedCrossRefGoogle Scholar
  27. 27.
    Bach N, Cuvillon D, Brouard J, et al.: Acute respiratory tract infections due to a human metapneumovirus in children: descriptive study and comparison with respiratory syncytial virus infections. Arch Pediatr 2004, 11:212–215.PubMedCrossRefGoogle Scholar
  28. 28.
    Falsey AR, Erdman D, Anderson LJ, Walsh EE: Human metapneumovirus infections in young and elderly adults. J Infect Dis 2003, 187:785–790.PubMedCrossRefGoogle Scholar
  29. 29.
    Stockton J, Stephenson I, Fleming D, Zambon M: Human metapneumovirus as a cause of community-acquired respiratory illness. Emerg Infect Dis 2002, 8:897–901.PubMedGoogle Scholar
  30. 30.
    Mackay IM, Jacob KC, Woolhouse D, et al.: Molecular assays for detection of human metapneumovirus. J Clin Microbiol 2003, 41:100–105.PubMedCrossRefGoogle Scholar
  31. 31.
    Cote S, Abed Y, Boivin G: Comparative evaluation of real-time PCR assays for detection of the human metapneumovirus. J Clin Microbiol 2003, 41:3631–3635.PubMedCrossRefGoogle Scholar
  32. 32.
    Maertzdorf J, Wang CK, Brown JB, et al.: Real-time reverse transcriptase PCR assay for detection of human metapneumoviruses from all known genetic lineages. J Clin Microbiol 2004, 42:981–986. This manuscript describes diagnostic methods for hMPV that have been validated against all known subgroups of hMPV.PubMedCrossRefGoogle Scholar
  33. 33.
    Rawlinson WD, Waliuzzaman Z, Carter IW, et al.: Asthma exacerbations in children associated with rhinovirus but not human metapneumovirus infection. J Infect Dis 2003, 187:1314–1318.PubMedCrossRefGoogle Scholar
  34. 34.
    Jartti T, van den Hoogen B, Garofalo RP, et al.: Metapneumovirus and acute wheezing in children. Lancet 2002, 360:1393–1394.PubMedCrossRefGoogle Scholar
  35. 35.
    Laham FR, Israele V, Casellas JM, et al.: Differential production of inflammatory cytokines in primary infection with human metapneumovirus and with other common respiratory viruses of infancy. J Infect Dis 2004, 189:2047–2056.PubMedCrossRefGoogle Scholar
  36. 36.
    Cane PA, van den Hoogen BG, Chakrabarti S, et al.: Human metapneumovirus in a haematopoietic stem cell transplant recipient with fatal lower respiratory tract disease. Bone Marrow Transplant 2003, 31:309–310.PubMedCrossRefGoogle Scholar
  37. 37.
    Pelletier G, Dery P, Abed Y, Boivin G: Respiratory tract reinfections by the new human metapneumovirus in an immunocompromised child. Emerg Infect Dis 2002, 8:976–978.PubMedGoogle Scholar
  38. 38.
    Madhi SA, Ludewick H, Abed Y, et al.: Human metapneumovirus-associated lower respiratory tract infections among hospitalized human immunodeficiency virus type 1 (HIV-1)-infected and HIV-1-uninfected African infants. Clin Infect Dis 2003, 37:1705–1710.PubMedCrossRefGoogle Scholar
  39. 39.
    Garcia ML, Calvo Rey C, Martin del Valle F, et al.: Respiratory infections due to metapneumovirus in hospitalized infants. Ann Pediatr (Barc) 2004, 61:213–218.CrossRefGoogle Scholar
  40. 40.
    Konig B, Konig W, Arnold R, et al.: Prospective study of human metapneumovirus infection in children less than 3 years of age. J Clin Microbiol 2004, 42:4632–4635.PubMedCrossRefGoogle Scholar
  41. 41.
    Greensill J, McNamara PS, Dove W, et al.: Human metapneumovirus in severe respiratory syncytial virus bronchiolitis. Emerg Infect Dis 2003, 9:372–375.PubMedGoogle Scholar
  42. 42.
    Semple MG, Cowell A, Dove W, et al.: Dual infection of infants by human metapneumovirus and human respiratory syncytial virus is strongly associated with severe bronchiolitis. J Infect Dis 2005, 191:382–386.PubMedCrossRefGoogle Scholar
  43. 43.
    Lazar I, Weibel C, Dziura J, et al.: Human metapneumovirus and severity of respiratory syncytial virus disease. Emerg Infect Dis 2004, 10:1318–1320.PubMedGoogle Scholar
  44. 44.
    Kuiken T, van den Hoogen BG, van Riel DA, et al.: Experimental human metapneumovirus infection of cynomolgus macaques (Macaca fascicularis) results in virus replication in ciliated epithelial cells and pneumocytes with associated lesions throughout the respiratory tract. Am J Pathol 2004, 164:1893–1900.PubMedGoogle Scholar
  45. 45.
    Alvarez R, Harrod KS, Shieh WJ, et al.: Human metapneumovirus persists in BALB/c mice despite the presence of neutralizing antibodies. J Virol 2004, 78:14003–14011.PubMedCrossRefGoogle Scholar
  46. 46.
    DeVincenzo JP, Hirsch RL, Fuentes RJ, Top FH Jr: Respiratory syncytial virus immune globulin treatment of lower respiratory tract infection in pediatric patients undergoing bone marrow transplantation--a compassionate use experience. Bone Marrow Transplant 2000, 25:161–165.PubMedCrossRefGoogle Scholar
  47. 47.
    Wyde PR, Chetty SN, Jewell AM, et al.: Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by ribavirin and immune serum globulin in vitro. Antiviral Res 2003, 60:51–59.PubMedCrossRefGoogle Scholar
  48. 48.
    Tang RS, Schickli JH, MacPhail M, et al.: Effects of human metapneumovirus and respiratory syncytial virus antigen insertion in two 3′ proximal genome positions of bovine/ human parainfluenza virus type 3 on virus replication and immunogenicity. J Virol 2003, 77:10819–10828.PubMedCrossRefGoogle Scholar
  49. 49.
    Biacchesi S, Skiadopoulos MH, Yang L, et al.: Recombinant human metapneumovirus lacking the small hydrophobic SH and/or attachment G glycoprotein: deletion of G yields a promising vaccine candidate. J Virol 2004, 78:12877–12887.PubMedCrossRefGoogle Scholar
  50. 50.
    Felsenstein J: PHYLIP home page. http://evolution.genetics. Accessed March 1, 2005.Google Scholar

Copyright information

© Current Science Inc 2005

Authors and Affiliations

  • John V. Williams
    • 1
  1. 1.Pediatric Infectious DiseasesVanderbilt University Medical Center, D-7235 Medical Center NorthNashvilleUSA

Personalised recommendations